CHERUVU PAVAN (Chief Executive Officer) received a stock award from SIO GENE THERAPIES INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/15/2020ACC: 0001209191-20-036807
DirectorOfficer· Chief Executive Officer
Since Apr 2019
-9.76K
Net shares
Net seller
$30.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
22.59K acquired · 32.35K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+22.59K
Price / share
—
Trade value
—
% of position
301.2%
6/11/2020
7.50K→30.09K
Common Shares
Direct
Shares
−9.76K
Price / share
$3.09
Trade value
$30.14K
% of position
32.4%
6/11/2020
30.09K→20.34K
Total
Net shares
+12.84K
Net value
-$30.14K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 6/11/2020 | A · Award | +22.59K | — | — | 301.2% | 7.50K | 30.09K |
| Common Shares Direct | 6/11/2020 | F · Tax Withholding | −9.76K | $3.09 | $30.14K | 32.4% | 30.09K | 20.34K |
| Total | +12.84K | -$30.14K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Shares
22.59K shares
Shares
−22.59K
Strike price
Held after
22.59K
Exercisable
—
6/11/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares22.59K shares | 6/11/2020 | D · Disposition | −22.59K | — | 22.59K |